Literature DB >> 1934266

The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.

R J Turesky1, J Markovic, I Bracco-Hammer, L B Fay.   

Abstract

The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) was investigated in the male Sprague-Dawley rat. Animals were given MeIQx by gavage at doses of 0.01, 0.2 or 20 mg/kg body wt. The phase II conjugates, MeIQx-N2 sulfamate and MeIQx-N2 glucuronide were the predominant metabolites found in urine of non-induced animals at the highest dose treatment. Animals induced with polychlorinated-biphenyl (PCB) produced greater amounts of metabolites hydroxylated at the 5 position of MeIQx which were excreted as glucuronide or sulfate conjugates. At the lowest dose studied, the urinary excretion profile was nearly identical for both animal groups and cytochrome P450 induction had little influence on metabolism. In contrast to high dose exposure, where sulfamate formation was a major route of detoxification, N2 glucuronide formation was the most important metabolic pathway for elimination of MeIQx at low doses. Liver microsomes transformed MeIQx to the genotoxic metabolite 2-hydroxyamino-3,8-dimethylimidazo[4,5-f]quinoxaline (HNOH-MeIQx) and N-hydroxylase activity was 20-fold greater in microsomes obtained from PCB-treated animals than in untreated control animals. The increase in N-hydroxylase activity was discerned in vivo through formation of the metastable N-glucuronide conjugate of HNOH-MeIQx (MeIQx-[HO-N]-Gl). This metabolite accounted for approximately 3% of the dose in bile of PCB-treated rats. In contrast, in the non-induced rat, MeIQx-[HO-N]-Gl was preferentially excreted in urine and accounted for approximately 0.2-1% of the total dose. These results demonstrate that the metabolism of MeIQx in the rat is influenced by both dose and cytochrome P450 induction. The absence of intestinal tumors in the non-induced rat may be partially attributed to the low levels of formation and poor biliary excretion of the N-glucuronide conjugate of the genotoxic metabolite HNOH-MeIQx.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934266     DOI: 10.1093/carcin/12.10.1847

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

Review 2.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

3.  A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.

Authors:  Dan Gu; Lynn McNaughton; David Lemaster; Brian G Lake; Nigel J Gooderham; Fred F Kadlubar; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

4.  Characterization of new metabolites from in vivo biotransformation of 2-amino-3-methylimidazo[4,5-f]quinoline in mouse by mass spectrometry.

Authors:  Fong-Fu Hsu; Vijaya M Lakshmi; Terry V Zenser
Journal:  J Mass Spectrom       Date:  2009-09       Impact factor: 1.982

5.  Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  Vijaya M Lakshmi; Fong Fu Hsu; Herman A J Schut; Terry V Zenser
Journal:  Chem Res Toxicol       Date:  2006-02       Impact factor: 3.739

Review 6.  Bacterial infection as a cause of cancer.

Authors:  J Parsonnet
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

7.  Heterocyclic amine-induced cancer and myocardial lesions in nonhuman primates.

Authors:  J S Felton
Journal:  Environ Health Perspect       Date:  1994-02       Impact factor: 9.031

8.  Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2.

Authors:  Akiyoshi Nishikawa; Fumio Furukawa; Makoto Miyauchi; Hwa-Young Son; Kazushi Okazaki; Akihiro Koide; Yukio Mori; Masao Hirose
Journal:  Jpn J Cancer Res       Date:  2002-01

9.  Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.

Authors:  R J Turesky; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.

Authors:  R J Turesky; G A Gross; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.